Literature DB >> 8753675

Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function.

W H Knapp1, C Dannenberg, B Marschall, D Zedlick, K Löschmann, S Bettin, H Barthel, A Seese.   

Abstract

Imaging of local cerebral blood flow (lCBF) may serve as an important supplementary tool in the aetiological assessment of dementias. In early or preclinical disease, however, there are less characteristic changes in lCBF. In the present study it was investigated whether vasoactivation or neuroactivation may produce more pronounced local lCBF deficits. Local CBF was investigated by using technetium-99m hexamethylpropylene amine oxime and single-photon emission tomography (SPET) in 80 patients (50 with mild cognitive impairment and 30 with dementia of Alzheimer type (DAT), all without evidence of cerebrovascular disease) at rest (baseline) and during activation. In 31 studies patients underwent vasomotor activation with acetazolamide, while 62 studies were performed under cognitive challenge (neuroactivation by labyrinth task). Cortical activity relative to that of cerebellum increased significantly in a right temporal region and tended to increase in other cortical regions upon vasoactivation. In contrast, neuroactivation reduced cortical activity relative to that of cerebellum in several left and right temporal and in left parietal regions. Visual classification of SPET images of patients with probable DAT by three observers resulted in a reduction of the number of definitely abnormal patterns from 9/12 to 4/12 by vasoactivation and an increase from 10/18 to 15/18 by neuroactivation. Correspondingly, abnormal ratings in patients with mild cognitive dysfunction were reduced from 7/19 to 5/19 by vasoactivation and were increased from 12/21 to 18/21 by neuroactivation. In conclusion, vasoactivation does not enhance local relative perfusion deficits in patients with cognitive impairment of non-vascular aetiology, whereas neuroactivation by labyrinth task produces more pronounced local flow differences and enhances abnormal patterns in lCBF imaging.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753675     DOI: 10.1007/bf01084360

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  46 in total

1.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

2.  A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity.

Authors:  A Dahl; K F Lindegaard; D Russell; R Nyberg-Hansen; K Rootwelt; W Sorteberg; H Nornes
Journal:  Stroke       Date:  1992-01       Impact factor: 7.914

3.  Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.

Authors:  J Kessler; K Herholz; M Grond; W D Heiss
Journal:  Neuropsychologia       Date:  1991       Impact factor: 3.139

4.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

5.  Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type.

Authors:  Y Kuwabara; Y Ichiya; M Otsuka; K Masuda; A Ichimiya; M Fujishima
Journal:  Stroke       Date:  1992-04       Impact factor: 7.914

6.  The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.

Authors:  R S Frackowiak; S Herold; R K Petty; J A Morgan-Hughes
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

7.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.

Authors:  D Neary; J S Snowden; R A Shields; A W Burjan; B Northen; N MacDermott; M C Prescott; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

8.  Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

Authors:  H G Gemmell; P F Sharp; J A Besson; J R Crawford; K P Ebmeier; J Davidson; F W Smith
Journal:  J Comput Assist Tomogr       Date:  1987 May-Jun       Impact factor: 1.826

9.  Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET.

Authors:  J D Miller; M J de Leon; S H Ferris; A Kluger; A E George; B Reisberg; H J Sachs; A P Wolf
Journal:  J Cereb Blood Flow Metab       Date:  1987-04       Impact factor: 6.200

10.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

Authors:  D Montaldi; D N Brooks; J H McColl; D Wyper; J Patterson; E Barron; J McCulloch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more
  5 in total

Review 1.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Qualitative versus quantitative assessment of cerebrovascular reactivity to acetazolamide using iodine-123-N-isopropyl-p-iodoamphetamine SPECT in patients with unilateral major cerebral artery occlusive disease.

Authors:  Kuniaki Ogasawara; Taku Okuguchi; Masayuki Sasoh; Masakazu Kobayashi; Hirotsugu Yukawa; Kazunori Terasaki; Takashi Inoue; Akira Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

Review 3.  Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?

Authors:  Luigi Yuri Di Marco; Eszter Farkas; Chris Martin; Annalena Venneri; Alejandro F Frangi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 4.  The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.086

Review 5.  Neurosonological Examination: A Non-Invasive Approach for the Detection of Cerebrovascular Impairment in AD.

Authors:  Barbora Urbanova; Ales Tomek; Robert Mikulik; Hana Magerova; Daniel Horinek; Jakub Hort
Journal:  Front Behav Neurosci       Date:  2014-01-21       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.